Literature DB >> 21628527

Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.

Etsuko Shibata1, Tarek Abbas, Xinhua Huang, James A Wohlschlegel, Anindya Dutta.   

Abstract

CRL4(Cdt2) is a cullin-based E3 ubiquitin ligase that promotes the ubiquitin-dependent proteolysis of various substrates implicated in the control of cell cycle and various DNA metabolic processes such as DNA replication and repair. Substrates for CRL4(Cdt2) E3 ubiquitin ligase include the replication licensing factor Cdt1 and the cyclin-dependent kinase (Cdk) inhibitor p21. Inhibition of this E3 ligase leads to serious abnormalities of the cell cycle and cell death. The ubiquitin-conjugating enzyme (UBC) involved in this important pathway, however, remains unknown. By a proteomic analysis of Cdt2-associated proteins and an RNA interference-based screening approach, we show that CRL4(Cdt2) utilizes two different UBCs to target different substrates. UBCH8, a member of the UBE2E family of UBCs, ubiquitylates and promotes the degradation of p21, both during the normal cell cycle and in UV-irradiated cells. Importantly, depletion of UBCH8 by small interfering RNA (siRNA) increases p21 protein level, delays entry into S phase of the cell cycle, and suppresses the DNA damage response after UV irradiation. On the other hand, members of the UBE2G family of UBCs (UBE2G1 and UBE2G2) cooperate with CRL4(Cdt2) to polyubiquitylate and degrade Cdt1 postradiation, an activity that is critical for preventing origin licensing in DNA-damaged cells. Finally, we show that UBCH8, but not UBE2G1 or UBE2G2, is required for CRL4(Cdt2)-mediated ubiquitylation and degradation of the histone H4 lysine 20 monomethyltransferase Set8, a previously identified CRL4(Cdt2) substrate, as well as for CRL4(Cdt2)-dependent monoubiquitylation of PCNA in unstressed cells. These findings identify the UBCs required for the activity of CRL4(Cdt2) on multiple substrates and demonstrate that different UBCs are involved in the selective ubiquitylation of different substrates by the same E3 complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628527      PMCID: PMC3147600          DOI: 10.1128/MCB.05496-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

2.  Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.

Authors:  Hideo Nishitani; Nozomi Sugimoto; Vassilis Roukos; Yohsuke Nakanishi; Masafumi Saijo; Chikashi Obuse; Toshiki Tsurimoto; Keiichi I Nakayama; Keiko Nakayama; Masatoshi Fujita; Zoi Lygerou; Takeharu Nishimoto
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

3.  PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication.

Authors:  Emily E Arias; Johannes C Walter
Journal:  Nat Cell Biol       Date:  2005-12-18       Impact factor: 28.824

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.

Authors:  R J Sheaff; J D Singer; J Swanger; M Smitherman; J M Roberts; B E Clurman
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

6.  The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells.

Authors:  Mathieu Tardat; Julien Brustel; Olivier Kirsh; Christine Lefevbre; Mary Callanan; Claude Sardet; Eric Julien
Journal:  Nat Cell Biol       Date:  2010-10-17       Impact factor: 28.824

7.  Mammalian DET1 regulates Cul4A activity and forms stable complexes with E2 ubiquitin-conjugating enzymes.

Authors:  Elah Pick; On-Sun Lau; Tomohiko Tsuge; Suchithra Menon; Yingchun Tong; Naoshi Dohmae; Scott M Plafker; Xing Wang Deng; Ning Wei
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

8.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.

Authors:  Youngjo Kim; Natalia G Starostina; Edward T Kipreos
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

9.  A chimeric ubiquitin conjugating enzyme that combines the cell cycle properties of CDC34 (UBC3) and the DNA repair properties of RAD6 (UBC2): implications for the structure, function and evolution of the E2s.

Authors:  E T Silver; T J Gwozd; C Ptak; M Goebl; M J Ellison
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

10.  Identification of a portable determinant of cell cycle function within the carboxyl-terminal domain of the yeast CDC34 (UBC3) ubiquitin conjugating (E2) enzyme.

Authors:  C J Kolman; J Toth; D K Gonda
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  28 in total

1.  Direct role for proliferating cell nuclear antigen in substrate recognition by the E3 ubiquitin ligase CRL4Cdt2.

Authors:  Courtney G Havens; Nadia Shobnam; Estrella Guarino; Richard C Centore; Lee Zou; Stephen E Kearsey; Johannes C Walter
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut.

Authors:  Dae Hong Kim; Jae Sam Hwang; Ik Hwan Lee; Seung Taek Nam; Ji Hong; Peng Zhang; Li Fang Lu; Junguee Lee; Heon Seok; Charalabos Pothoulakis; John Thomas Lamont; Ho Kim
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

Review 3.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  An in vitro attempt at precision toxicology reveals the involvement of DNA methylation alteration in ochratoxin A-induced G0/G1 phase arrest.

Authors:  Boyang Zhang; Liye Zhu; Yaqi Dai; Hongyu Li; Kunlun Huang; Yunbo Luo; Wentao Xu
Journal:  Epigenetics       Date:  2019-07-22       Impact factor: 4.528

5.  The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity.

Authors:  Radhika Raheja; Yuhui Liu; Ellen Hukkelhoven; Nancy Yeh; Andrew Koff
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

6.  Two different replication factor C proteins, Ctf18 and RFC1, separately control PCNA-CRL4Cdt2-mediated Cdt1 proteolysis during S phase and following UV irradiation.

Authors:  Yasushi Shiomi; Akiyo Hayashi; Takashi Ishii; Kaori Shinmyozu; Jun-ichi Nakayama; Kaoru Sugasawa; Hideo Nishitani
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

7.  Expression analysis of genes of ubiquitin-proteasome protein degradation system in MPTP-induced mice models of early stages of Parkinson's disease.

Authors:  E V Filatova; M I Shadrina; A Kh Alieva; A A Kolacheva; P A Slominsky; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2014-07-04       Impact factor: 0.788

8.  Snai2 and Snai3 transcriptionally regulate cellular fitness and functionality of T cell lineages through distinct gene programs.

Authors:  Peter D Pioli; Sarah K Whiteside; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2016-01-22       Impact factor: 3.144

9.  Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair.

Authors:  Christine K Schmidt; Yaron Galanty; Matylda Sczaniecka-Clift; Julia Coates; Satpal Jhujh; Mukerrem Demir; Matthew Cornwell; Petra Beli; Stephen P Jackson
Journal:  Nat Cell Biol       Date:  2015-10-26       Impact factor: 28.824

Review 10.  The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.

Authors:  Florian Bassermann; Ruth Eichner; Michele Pagano
Journal:  Biochim Biophys Acta       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.